Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

Apalutamide in Treating Patients With Prostate Cancer Who Are in Active Surveillance

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02721979
Recruitment Status : Recruiting
First Posted : March 29, 2016
Last Update Posted : February 5, 2020
Janssen Scientific Affairs, LLC
National Cancer Institute (NCI)
Information provided by (Responsible Party):
University of Washington

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : May 2, 2020
Estimated Study Completion Date : November 2, 2021